Literature DB >> 2782761

Respiratory risk factors and mortality: longitudinal studies in Washington County, Maryland.

M S Tockman1, G W Comstock.   

Abstract

Risk factors for temporal changes in chronic respiratory disease mortality were evaluated from two studies conducted in Washington County, Maryland. The first examined the mortality of a private census population (greater than 35,000 whites) enumerated in 1963 over two subsequent time periods by age, sex, and initial smoking status. The second examined the 10-yr mortality of a subset of the 1963 census (884 men who had undergone spirometry). We observed a fall in age-adjusted mortality from all causes and from arteriosclerotic heart disease (ASHD), but an increase in COPD mortality. However, the increase in these chronic pulmonary deaths is essentially confined to persons who were smoking cigarettes at the beginning of the study period. Furthermore, while smokers showed an increased mortality risk for all causes, the excess mortality risk did not fall uniformly across cigarette smokers. It is a major observation of this study that all-cause and cardiovascular (as well as pulmonary) mortality are significantly more often found among subjects with ventilatory impairment (independent of smoking status). Reasons for the association of ASHD mortality with impaired forced expiration are discussed. Thus, men at increased risk for three (ASHD, lung cancer, COPD) of the five leading causes of death (three of eight for women) may be identified by spirometry. Perhaps it is time that this test was more generally applied.

Entities:  

Mesh:

Year:  1989        PMID: 2782761     DOI: 10.1164/ajrccm/140.3_Pt_2.S56

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  20 in total

Review 1.  [Comorbidities of COPD].

Authors:  H Watz; H Magnussen
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

2.  Chronic productive cough is associated with death in smokers with early COPD.

Authors:  Nirupama Putcha; M Bradley Drummond; John E Connett; Paul D Scanlon; Donald P Tashkin; Nadia N Hansel; Robert A Wise
Journal:  COPD       Date:  2013-10-15       Impact factor: 2.409

3.  Chronic Bronchitis: Where Are We Now?

Authors:  Yaniv Dotan; Jennifer Y So; Victor Kim
Journal:  Chronic Obstr Pulm Dis       Date:  2019-04-09

4.  [COPD and heart disease].

Authors:  H Watz; M Arzt
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

5.  Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study.

Authors:  R G Barr; F S Ahmed; J J Carr; E A Hoffman; R Jiang; S M Kawut; K Watson
Journal:  Eur Respir J       Date:  2011-10-27       Impact factor: 16.671

6.  Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men.

Authors:  M Pelkonen; H Tukiainen; M Tervahauta; I L Notkola; S L Kivelä; Y Salorinne; A Nissinen
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

7.  Association of lung function with coronary heart disease and cardiovascular disease outcomes in elderly: the Rancho Bernardo study.

Authors:  Hwa Mu Lee; Michael A Liu; Elizabeth Barrett-Connor; Nathan D Wong
Journal:  Respir Med       Date:  2014-10-06       Impact factor: 3.415

8.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study.

Authors:  D J Hole; G C Watt; G Davey-Smith; C L Hart; C R Gillis; V M Hawthorne
Journal:  BMJ       Date:  1996-09-21

9.  A role for Wnt signaling genes in the pathogenesis of impaired lung function in asthma.

Authors:  Sunita Sharma; Kelan Tantisira; Vincent Carey; Amy J Murphy; Jessica Lasky-Su; Juan C Celedón; Ross Lazarus; Barbara Klanderman; Angela Rogers; Manuel Soto-Quirós; Lydiana Avila; Thomas Mariani; Roger Gaedigk; Stephen Leeder; John Torday; David Warburton; Benjamin Raby; Scott T Weiss
Journal:  Am J Respir Crit Care Med       Date:  2009-11-19       Impact factor: 21.405

Review 10.  Chronic bronchitis and chronic obstructive pulmonary disease.

Authors:  Victor Kim; Gerard J Criner
Journal:  Am J Respir Crit Care Med       Date:  2012-11-29       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.